id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
813,,,,,,,,,,,,,,,2024-05-30T14:09:58+06:00,BSH - R181003152,Left,Letrozole + Zoledronic acid.,,,"Carcinoma Left Breast, Post Op, pT1N1Mx, ER/PR +ve, HER2- Negative, Post CT, Post RT (Nov
2014), On HT(Letrozole) and Zoledronic acid.",2023-05-08,,2023-05-08,,,,,Breast,119,Upper middle class,BSBSC-240000119,RUMANA AHMED,1712001002,1964-08-02,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,Stable,Alive,,,,,,,,,,,,,,,,,,CA15.3,17.7,,2019-01-12,813.0
850,,,,,,,,,,,,,,,2024-05-30T14:09:58+06:00,BSH - R181003152,Left,Letrozole + Zoledronic acid.,,,"Carcinoma Left Breast, Post Op, pT1N1Mx, ER/PR +ve, HER2- Negative, Post CT, Post RT (Nov
2014), On HT(Letrozole) and Zoledronic acid.",2023-05-08,,2023-05-08,,,,,Breast,119,Upper middle class,BSBSC-240000119,RUMANA AHMED,1712001002,1964-08-02,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,Stable,Alive,,,,,,,,,,,,,,,,,,CA15.3,17.7,,2019-01-12,850.0
813,,,,,,,,,,,,,,,2024-05-30T14:09:58+06:00,BSH - R181003152,Left,Letrozole + Zoledronic acid.,,,"Carcinoma Left Breast, Post Op, pT1N1Mx, ER/PR +ve, HER2- Negative, Post CT, Post RT (Nov
2014), On HT(Letrozole) and Zoledronic acid.",2023-05-08,,2023-05-08,,,,,Breast,119,Upper middle class,BSBSC-240000119,RUMANA AHMED,1712001002,1964-08-02,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,Stable,Alive,,,,,,,,,,,,,,,,,,CA15.3,11.0,,2019-10-14,813.0
850,,,,,,,,,,,,,,,2024-05-30T14:09:58+06:00,BSH - R181003152,Left,Letrozole + Zoledronic acid.,,,"Carcinoma Left Breast, Post Op, pT1N1Mx, ER/PR +ve, HER2- Negative, Post CT, Post RT (Nov
2014), On HT(Letrozole) and Zoledronic acid.",2023-05-08,,2023-05-08,,,,,Breast,119,Upper middle class,BSBSC-240000119,RUMANA AHMED,1712001002,1964-08-02,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,Stable,Alive,,,,,,,,,,,,,,,,,,CA15.3,11.0,,2019-10-14,850.0
813,,,,,,,,,,,,,,,2024-05-30T14:09:58+06:00,BSH - R181003152,Left,Letrozole + Zoledronic acid.,,,"Carcinoma Left Breast, Post Op, pT1N1Mx, ER/PR +ve, HER2- Negative, Post CT, Post RT (Nov
2014), On HT(Letrozole) and Zoledronic acid.",2023-05-08,,2023-05-08,,,,,Breast,119,Upper middle class,BSBSC-240000119,RUMANA AHMED,1712001002,1964-08-02,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,Stable,Alive,,,,,,,,,,,,,,,,,,CA15.3,7.2,,2020-09-22,813.0
850,,,,,,,,,,,,,,,2024-05-30T14:09:58+06:00,BSH - R181003152,Left,Letrozole + Zoledronic acid.,,,"Carcinoma Left Breast, Post Op, pT1N1Mx, ER/PR +ve, HER2- Negative, Post CT, Post RT (Nov
2014), On HT(Letrozole) and Zoledronic acid.",2023-05-08,,2023-05-08,,,,,Breast,119,Upper middle class,BSBSC-240000119,RUMANA AHMED,1712001002,1964-08-02,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,Stable,Alive,,,,,,,,,,,,,,,,,,CA15.3,7.2,,2020-09-22,850.0
813,,,,,,,,,,,,,,,2024-05-30T14:09:58+06:00,BSH - R181003152,Left,Letrozole + Zoledronic acid.,,,"Carcinoma Left Breast, Post Op, pT1N1Mx, ER/PR +ve, HER2- Negative, Post CT, Post RT (Nov
2014), On HT(Letrozole) and Zoledronic acid.",2023-05-08,,2023-05-08,,,,,Breast,119,Upper middle class,BSBSC-240000119,RUMANA AHMED,1712001002,1964-08-02,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,Stable,Alive,,,,,,,,,,,,,,,,,,Others,228.42,,2022-10-19,813.0
850,,,,,,,,,,,,,,,2024-05-30T14:09:58+06:00,BSH - R181003152,Left,Letrozole + Zoledronic acid.,,,"Carcinoma Left Breast, Post Op, pT1N1Mx, ER/PR +ve, HER2- Negative, Post CT, Post RT (Nov
2014), On HT(Letrozole) and Zoledronic acid.",2023-05-08,,2023-05-08,,,,,Breast,119,Upper middle class,BSBSC-240000119,RUMANA AHMED,1712001002,1964-08-02,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,Stable,Alive,,,,,,,,,,,,,,,,,,Others,228.42,,2022-10-19,850.0
